Ab&B Bio-Tech Co Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
580
- Stock Symbol
-
02627
- Share Price
-
$3.74
- (As of Tuesday Closing)
Ab&B Bio-Tech Co General Information
Description
Ab&B Bio-Tech Co Ltd JS is a China-based vaccine company dedicated to the research, development, manufacturing and commercialization of innovative vaccines and traditional vaccines adopting new technical methods. Its pipeline included two Core Products, the quadrivalent subunit influenza vaccine and lyophilized human rabies vaccine candidate, along with 11 other vaccine candidates.
Contact Information
Website
www.abbbio.comCorporate Office
- No.32 Xinglin Road, Medical High-tech Zone
- Taizhou, Jiangsu
- China
Corporate Office
- No.32 Xinglin Road, Medical High-tech Zone
- Taizhou, Jiangsu
- China
Ab&B Bio-Tech Co Stock Performance
As of 31-Mar-2026, Ab&B Bio-Tech Co’s stock price is $3.74. Its current market cap is $1.47B with 393M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.74 | $3.78 | $3.69 - $9.33 | $1.47B | 393M | 632K | -$0.08 |
Ab&B Bio-Tech Co Financials Summary
As of 30-Jun-2025, Ab&B Bio-Tech Co has a trailing 12-month revenue of $44.9M.
|
In Thousands, USD |
TTM 30-Jun-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|
| Revenue | 44,860 | 36,181 | 7,374 |
| EBITDA | (28,326) | (25,403) | (52,766) |
| Net Income | (31,097) | (36,056) | (60,035) |
| Total Assets | 203,205 | 220,934 | 157,964 |
| Total Debt | 127,771 | 117,643 | 59,451 |
Ab&B Bio-Tech Co Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ab&B Bio-Tech Co Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ab&B Bio-Tech Co Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ab&B Bio-Tech Co Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ab&B Bio-Tech Co ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Ab&B Bio-Tech Co FAQs
-
When was Ab&B Bio-Tech Co founded?
Ab&B Bio-Tech Co was founded in 2015.
-
Where is Ab&B Bio-Tech Co headquartered?
Ab&B Bio-Tech Co is headquartered in Taizhou, China.
-
What is the size of Ab&B Bio-Tech Co?
Ab&B Bio-Tech Co has 580 total employees.
-
What industry is Ab&B Bio-Tech Co in?
Ab&B Bio-Tech Co’s primary industry is Drug Discovery.
-
Is Ab&B Bio-Tech Co a private or public company?
Ab&B Bio-Tech Co is a Public company.
-
What is Ab&B Bio-Tech Co’s stock symbol?
The ticker symbol for Ab&B Bio-Tech Co is 02627.
-
What is the current stock price of Ab&B Bio-Tech Co?
As of 31-Mar-2026 the stock price of Ab&B Bio-Tech Co is $3.74.
-
What is the current market cap of Ab&B Bio-Tech Co?
The current market capitalization of Ab&B Bio-Tech Co is $1.47B.
-
What is Ab&B Bio-Tech Co’s current revenue?
The trailing twelve month revenue for Ab&B Bio-Tech Co is $44.9M.
-
What is Ab&B Bio-Tech Co’s annual earnings per share (EPS)?
Ab&B Bio-Tech Co’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
